Bone Biologics prices $3.0M private placement with up to $6.0M in warrant proceeds

Bone Biologics Corp

Gross proceeds of ~$3.0M from sale of 2,112,677 pre-funded warrants and Series F/G warrants at $1.419 per unit.
Potential additional ~$6.0M if Series F (5-year) and Series G (18-month) warrants fully exercised at $1.42/share.
Net proceeds ~$2.7M after fees; intended for clinical trials, patent portfolio, and working capital.
H.C. Wainwright acted as exclusive placement agent; received 7.0% cash fee and 126,761 placement agent warrants.
Company to seek stockholder approval for warrant issuance; resale registration statement to be filed within 15 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.